Centocor Ortho acquires maker of inhaled treatments

06/1/2010 | American City Business Journals

Centocor Ortho Biotech acquired RespiVert, which specializes in small-molecule, inhaled drugs for pulmonary diseases, for an undisclosed amount. "The addition of RespiVert's expert scientific team and discovery platforms for inhaled medicines strengthens our capabilities and further builds our pipeline of novel oral and biologic therapies for serious pulmonary diseases," said an official at Centocor Research and Development.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC